Radiofrequency in Onychomycosis

Non Ablative Radiofrequency in the Treatment of Onychomycosis, a Pilot Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05390190

Enrollment

Registered

2022-05-25

Start date

2022-07-01

Completion date

2022-10-01

Last updated

2022-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onychomycosis

Brief summary

Onychomycosis is the most common nail disease, representing more than 50% of all onychopathies.

Detailed description

Treatments with antifungals may not be successful due to several factors, including the long time required to apply topical medications, the side effects of systemic drugs, and the application of insufficient medication to the target area. Non-ablative radiofrequency devices can be used to treat onychomycosis without harming the nail matrix cells.

Interventions

DEVICENon ablative radiofrequency

Device

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Onychomycosis patients

Exclusion criteria

Patients with excessive manual work

Design outcomes

Primary

Measure	Time frame	Description
Onychomycosis severity index	3 months	Clinical assessment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026